Sprogoe; Kennett
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sprogoe; Kennett.The latest application filed is for "controlled-release cnp agonists with low npr-c binding".
Company Profile
2.20.45
- Sprogoe; Kennett - Holte DK
- SPROGOE; Kennett - Hellerup DK
- Sprogoe; Kennett - Helleru DK
- Sprogoe; Kennett - Palo Alto CA
- Sprogoe; Kennett - Denmark DK
- Sprogoe; Kennett - Ishoj N/A DK
Patent Activity
| Patent | Date |
|---|---|
| Controlled-release CNP agonists with low initial NPR-B activity Grant 11,389,510 - Sprogoe , et al. July 19, 2 | 2022-07-19 |
| Controlled-release CNP agonists with reduced side-effects Grant 11,389,511 - Sprogoe , et al. July 19, 2 | 2022-07-19 |
| Controlled-release Cnp Agonists With Low Npr-c Binding App 20220211817 - Rau; Harald ; et al. | 2022-07-07 |
| Controlled-release CNP agonists with low NPR-C binding Grant 11,311,604 - Rau , et al. April 26, 2 | 2022-04-26 |
| Liquid Pharmaceutical Formulations of PTH Conjugates App 20220088149 - SKANDS; Anja R.H. ; et al. | 2022-03-24 |
| Long-acting Growth Hormone Dosage Forms With Superior Efficacy To Daily Somatropin App 20220088147 - SPROGOE; Kennett | 2022-03-24 |
| Controlled-release Cnp Agonists With Increased Nep Stability App 20220088206 - SPROGOE; Kennett ; et al. | 2022-03-24 |
| Conjugates Of Pattern Recognition Receptor Agonists App 20220062273 - SPROGOE; Kennett ; et al. | 2022-03-03 |
| Sustained Local Drug Levels For Innate Immune Agonists App 20220054476 - ROSEN; David B. ; et al. | 2022-02-24 |
| Minimization Of Systemic Inflammation App 20220054478 - ROSEN; David B. ; et al. | 2022-02-24 |
| Induction Of Sustained Local Inflammation App 20220054477 - ROSEN; David B. ; et al. | 2022-02-24 |
| Controlled-release CNP agonists with increased NEP stability Grant 11,224,661 - Sprogoe , et al. January 18, 2 | 2022-01-18 |
| PTH Prodrugs App 20220008516 - Sprogoe; Kennett ; et al. | 2022-01-13 |
| Treatment Of Infections App 20210330798 - SPROGOE; Kennett ; et al. | 2021-10-28 |
| PEGylated Recombinant Human Growth Hormone Compounds App 20210220442 - Rau; Harald ; et al. | 2021-07-22 |
| Starting Dose of PTH Conjugates App 20210196801 - Sprogoe; Kennett ; et al. | 2021-07-01 |
| Diagnosis, prevention and treatment of diseases of the joint Grant 10,980,860 - Vetter , et al. April 20, 2 | 2021-04-20 |
| PEGylated recombinant human growth hormone compounds Grant 10,960,053 - Rau , et al. March 30, 2 | 2021-03-30 |
| Cnp Prodrugs App 20210069339 - Sprogoe; Kennett ; et al. | 2021-03-11 |
| IL-2 Conjugates App 20210024602 - Sprogoe; Kennett ; et al. | 2021-01-28 |
| Conjugates App 20210008168 - Knappe; Thomas` ; et al. | 2021-01-14 |
| Pth Prodrugs App 20200376089 - Sprogoe; Kennett ; et al. | 2020-12-03 |
| Pth Compounds With Low Peak-to-trough Ratios App 20200360488 - Sprogoe; Kennett ; et al. | 2020-11-19 |
| Pth Prodrugs App 20200360487 - Sprogoe; Kennett ; et al. | 2020-11-19 |
| Combination Therapy with Controlled-Release CNP Agonists App 20200276270 - Holten-Andersen; Lars ; et al. | 2020-09-03 |
| PTH Prodrugs App 20200276276 - Sprogoe; Kennett ; et al. | 2020-09-03 |
| Carrier-linked treprostinil prodrugs Grant 10,729,778 - Hersel , et al. | 2020-08-04 |
| Dosage Regimen for a Controlled-Release PTH Compound App 20200023041 - Holten-Andersen; Lars ; et al. | 2020-01-23 |
| VEGF neutralizing prodrugs for the treatment of ocular conditions Grant 10,519,226 - Rau , et al. Dec | 2019-12-31 |
| Controlled-release Cnp Agonists With Low Initial Npr-b Activity App 20190328840 - SPROGOE; Kennett ; et al. | 2019-10-31 |
| Controlled-release Cnp Agonists With Reduced Side-effects App 20190328841 - Sprogoe; Kennett ; et al. | 2019-10-31 |
| PTH Compounds with Low Peak-To-Trough Ratios App 20190282668 - Sprogoe; Kennett ; et al. | 2019-09-19 |
| Cnp Prodrugs App 20190255183 - Sprogoe; Kennett ; et al. | 2019-08-22 |
| PEGylated Recombinant Human Growth Hormone Compounds App 20190192634 - Rau; Harald ; et al. | 2019-06-27 |
| Carrier-Linked Treprostinil Prodrugs App 20190105400 - Hersel; Ulrich ; et al. | 2019-04-11 |
| Controlled-release Cnp Agonists With Increased Nep Stability App 20190022237 - SPROGOE; Kennett ; et al. | 2019-01-24 |
| Controlled-release Cnp Agonists With Low Npr-c Binding App 20190000926 - Rau; Harald ; et al. | 2019-01-03 |
| PEGylated Recombinant Human Growth Hormone Compounds Grant 10,098,930 - Rau , et al. October 16, 2 | 2018-10-16 |
| Sustained release composition of prostacyclin Grant 9,872,864 - Sprogoe , et al. January 23, 2 | 2018-01-23 |
| Cnp Prodrugs App 20170368189 - SPROGOE; Kennett ; et al. | 2017-12-28 |
| Long-Acting Growth Hormone Dosage Forms App 20170312342 - Sprogoe; Kennett ; et al. | 2017-11-02 |
| Prevention And Treatment Of Ocular Conditions App 20170112939 - KNAPPE; Thomas ; et al. | 2017-04-27 |
| Carrier-linked treprostinil prodrugs Grant 9,561,287 - Hersel , et al. February 7, 2 | 2017-02-07 |
| Relaxin Prodrugs App 20160296600 - Sprogoe; Kennett ; et al. | 2016-10-13 |
| PEGylated Recombinant Human Growth Hormone Compounds App 20160206702 - Rau; Harald ; et al. | 2016-07-21 |
| PEGylated recombinant human growth hormone compounds Grant 9,272,048 - Rau , et al. March 1, 2 | 2016-03-01 |
| Long acting insulin composition Grant 9,265,723 - Sprogoe , et al. February 23, 2 | 2016-02-23 |
| VEGF Neutralizing Prodrugs for the Treatment of Ocular Conditions App 20150297740 - RAU; Harald ; et al. | 2015-10-22 |
| Diagnosis, Prevention And Treatment Of Diseases Of The Joint App 20150290337 - Vetter; Dirk ; et al. | 2015-10-15 |
| Prevention And Treatment Of Ocular Conditions App 20150010634 - Knappe; Thomas ; et al. | 2015-01-08 |
| Sustained Release Composition of Prostacyclin App 20140303245 - Sprogoe; Kennett ; et al. | 2014-10-09 |
| Carrier-Linked Treprostinil Prodrugs App 20140296150 - Hersel; Ulrich ; et al. | 2014-10-02 |
| Subcutaneous paliperidone composition Grant 8,758,780 - Sprogoe , et al. June 24, 2 | 2014-06-24 |
| Subcutaneous Paliperidone Composition App 20120277253 - Sprogoe; Kennett ; et al. | 2012-11-01 |
| Long Acting Insulin Composition App 20120183616 - Sprogoe; Kennett ; et al. | 2012-07-19 |
| Pegylated Recombinant Human Growth Hormone Compounds App 20110112021 - Rau; Harald ; et al. | 2011-05-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 